Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients
Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the pharmacokinetics (PK) of apixaban in kidney and lung
transplant recipients stabilized on either cyclosporine or tacrolimus as part of their
immunosuppressive therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Saskatchewan
Collaborators:
Lung Association of Saskatchewan Saskatchewan Health Research Foundation